HK1006414A1 - Medicament for augmenting fetal hemoglobin - Google Patents

Medicament for augmenting fetal hemoglobin

Info

Publication number
HK1006414A1
HK1006414A1 HK98105691A HK98105691A HK1006414A1 HK 1006414 A1 HK1006414 A1 HK 1006414A1 HK 98105691 A HK98105691 A HK 98105691A HK 98105691 A HK98105691 A HK 98105691A HK 1006414 A1 HK1006414 A1 HK 1006414A1
Authority
HK
Hong Kong
Prior art keywords
augmenting
medicament
fetal hemoglobin
hemoglobin
fetal
Prior art date
Application number
HK98105691A
Other languages
English (en)
Inventor
Susan Perrine
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Publication of HK1006414A1 publication Critical patent/HK1006414A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
HK98105691A 1988-11-29 1998-06-18 Medicament for augmenting fetal hemoglobin HK1006414A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27715188A 1988-11-29 1988-11-29

Publications (1)

Publication Number Publication Date
HK1006414A1 true HK1006414A1 (en) 1999-02-26

Family

ID=23059612

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105691A HK1006414A1 (en) 1988-11-29 1998-06-18 Medicament for augmenting fetal hemoglobin

Country Status (4)

Country Link
EP (1) EP0371789B1 (de)
GR (1) GR3023006T3 (de)
HK (1) HK1006414A1 (de)
SG (1) SG86966A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439939A (en) * 1992-03-17 1995-08-08 Children's Hospital Medical Center Of Northern California Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
IT1273628B (it) * 1993-06-04 1997-07-08 Emerging Pharmaceutical Techno Composizioni farmaceutiche per la cura della talassemia contenenti derivati dell'acido butirrico e in particolare isobutirramide
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
US6130248A (en) * 1996-12-30 2000-10-10 Bar-Ilan University Tricarboxylic acid-containing oxyalkyl esters and uses thereof
US6110955A (en) * 1997-03-11 2000-08-29 Beacon Laboratories, Inc. Metabolically stabilized oxyalkylene esters and uses thereof
US5939455A (en) * 1997-03-11 1999-08-17 Beacon Laboratories, Inc. Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives
US6110970A (en) * 1997-03-11 2000-08-29 Beacon Laboratories, Inc. Nitrogen-containing oxyalkylene esters and uses thereof
US6043389A (en) * 1997-03-11 2000-03-28 Mor Research Applications, Ltd. Hydroxy and ether-containing oxyalkylene esters and uses thereof
US6030961A (en) * 1997-03-11 2000-02-29 Bar-Ilan Research & Development Co., Ltd. Oxyalkylene phosphate compounds and uses thereof
US6124495A (en) * 1997-03-11 2000-09-26 Beacon Laboratories, Inc. Unsaturated oxyalkylene esters and uses thereof
CN101489544A (zh) * 2006-05-09 2009-07-22 海玛奎斯特医药公司 治疗血液病的方法
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
CN102802412A (zh) 2009-12-08 2012-11-28 海玛奎斯特医药公司 用于治疗红细胞病症的方法及低剂量方案
US20110245154A1 (en) 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
EP3976198A4 (de) 2019-05-31 2023-07-19 Viracta Subsidiary, Inc. Verfahren zur behandlung von viral assoziiertem krebs mit histon-deacetylase-inhibitoren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482571A (en) * 1982-06-21 1984-11-13 University Of Pittsburgh Sickle cell anemia treatment and compound
US4822821A (en) * 1986-10-10 1989-04-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin

Also Published As

Publication number Publication date
EP0371789A3 (de) 1991-10-02
EP0371789B1 (de) 1997-01-02
EP0371789A2 (de) 1990-06-06
GR3023006T3 (en) 1997-07-30
SG86966A1 (en) 2002-03-19

Similar Documents

Publication Publication Date Title
GB8819304D0 (en) Fetal oximeter electrode
GR3023006T3 (en) Medicament for augmenting fetal hemoglobin
GB2222963B (en) Catalysts
GB8924052D0 (en) Pharmaceutical solution
GB8905815D0 (en) Medicament
ZA899833B (en) Blood separating agent
ZA897283B (en) Obstetric bed
HU895714D0 (en) Syringe for single use
GB2228872B (en) Skin exciser
GB2218912B (en) Surgical retractor
GB8822157D0 (en) Tissue modification
EP0413721A4 (en) Human gm-csf variants
GB8913421D0 (en) Disposable shoe-cleaning package
GB8807186D0 (en) Surgical vizors
GB8815713D0 (en) Medical device
GB8810252D0 (en) Autoclave
GB2223948B (en) Autoclave container
IE883611L (en) Griseolic acid monoesters
GB8811797D0 (en) Medical electropromt
GB8810254D0 (en) Autoclave
IE893154L (en) Medical package
GB8821819D0 (en) Medicine
GB8802730D0 (en) Catalyst preparation
GB8817540D0 (en) Catalyst preparation
GB8705553D0 (en) Medicament

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20051129